Algernon Pharmaceuticals Inc C.AGN

This game isn’t over $$$

[Mole101]

 

 

 

 

@Hasetohru

·

2h

 

 

Exactly as we expected the power of Ifenprodil to COVID-19 toxicity, Ifenprodil is a real silver power for our human lives.

Quote Tweet

 

 

 

Algernon Pharmaceuticals

 

@AlgernonPharma

· 10h

NEWS RELEASE: We are pleased to announce topline data from the Phase 2b part of our Phase 2b/3 #COVID-19 trial of Ifenprodil. We look forward to completing our final data review and receiving feedback from the @US_FDA. Details: https://bit.ly/3rzo9yl

[Mole101]

  @Hasetohru · 3h     Exactly as we expected the power of Ifenprodil to COVID-19 toxicity, Ifenprodil is a real silver power for our human lives.

[Qtrlbder]

That's right! IMHO, the top line data is showing good results thus far. What happened today is "sell on the news" and weak hand usually get flush out. I am holding on to my shares and gonna wait until the final data is release.

[TheBearInTheWoods]

Good luck raising 50 mil for a phase 3 at .25 with a drug without a patent that's ineffective at higher dose, you guys have some serious Stockholm syndrome 

[Laliberte2020]

Speaking of Stockholm syndrome, you hate the stock and the company but you come here everyday.............. And the way I read it is the high dose is not more effective than the low dose, not ineffective. Glta

[Qtrlbder]

Sound like a paid basher

[Mole101]

Bear is in love with  Arch Biopartnets , (The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway.)... I think he views this as a" I win you loose" kind of game and that's why he comes by ones in a wile , just to make himself feel good about his investment . 

[Arbourmark]

Arch Bio Partners is the real deal. They definitely have credibility as Federal government gave them close to $7M grant toward their phase 2 Covid study. They have phase 2 trials going in Turkey, two hospitals in Calgary and one in  Fort Lauderdale. The phase 2 study must have shown positive results as the Turkish Health Authority extended the Phase 2 to dose another 20 patients. The